Paratesticular liposarcoma: a case report

Paratesticular liposarcoma: a case report

Karima Mouden^1,&,, Soukaina Wakrim², Afaf Semmar¹

¹Department of Radiation Oncology, National Oncology Institute, Rabat, Morocco, ²Department of Radiology, Ibn Zohr University, Faculty of Medicine and Pharmacy, Agadir, Morocco

^&Corresponding author
Karima Mouden, Department of Radiation Oncology, National Oncology Institute, Rabat, Morocco

Introduction    

Paratesticular liposarcomas (PLS) are rare variant of genitourinary malignancies, occurring more often in the spermatic cord where it accounts for less than 12% of all liposarcomas [1, 2]. About 200 paratesticular liposarcomas were reported to date in the English literature [3]. Due to the scarcity of cases, there is no consensus on the best PLS treatment, and this entity is still challenging clinicians. In this paper, we report a case of a giant well-differentiated paratesticular liposarcoma of the left testis with a left pelvic mass measuring 15x7x17 cm. We present this case because giant PLS is more rare with only a few cases having been reported [4, 5].

Patient and observation     

A previously healthy 55-year-old man presented with an increasing scrotal swelling lasting for 2-years. Examination revealed a left hard hemiscrotal mass, distinct from the left testis, measuring approximately 15 cm × 12.5 cm. A scrotal exploration was performed under general anaesthetic where a large left groin mass was found separate to the testis; however, with suspicions for underlying mass, a left orchidectomy was performed. Microscopically, the tumor had lipoblasts with atypical nucleus indented on its surfaces by fat vacuoles and stromal cells with hyperchromatic nuclei (Figure 1). The histopathologic diagnosis was consistent with well-differentiated spermatic cord liposarcoma with positive spermatic cord margins. Computed tomography showed a left lateroplevic lipomatous mass extended to the iliac fossa and left parietocolic gutter up to the umbilicus measuring 15x7x17 cm repressing the bladder, sigmoid, left colon, some ileal loops and encompassing the left external iliac pedicle and left pathological external iliac lymph nodes measuring 15 mm (Figure 2). A staging CT of the thorax, abdomen and pelvis was performed which was negative for metastatic disease. Following completion excision of the spermatic, hemiscrotectomy and resection of the pelvic tumor, the case was referred to a sarcoma unit, but patient refused treatment.

Discussion     

Paratesticular liposarcomas, which account for 7% to 10% of all intrascrotal tumors, have their mesodermal origin derived from adipose tissue. The most common site of origin is the spermatic cord accounting for 90% of cases [6]. There are few cases of giant PLS reported to date in the English literature [4, 5]. Liposarcomas are the most common soft tissue sarcomas. There are five histological subtypes in liposarcoma, which include well differentiated/atypical lipomatous tumor, dedifferentiated, myxoid and pleomorphic according to the 2013 World Health Organisation (WHO) classification of tumors of soft tissue and bone [7]. Our case noticed the swelling in his inguinal region two years earlier. It was mistaken for scrotal hernia like other patients reported in review of the literature [8, 9]. The diagnosis of PLS is documented by Ultrasonography (US), Computerized Tomography (CT) and Magnetic Resonance Imaging (MRI) [10]. Due to rarity of PLS, knowledge has been limited almost exclusively to case reports. The most widely used local treatment approaches include: radical orchiectomy with high ligation of the spermatic cord at the inguinal ring [6]. Incomplete excision is associated with frequent recurrence [11-13]. Khandekar et al. found that the 3 year local recurrence free survival was 100% for negative margins compared with 29% for positive margins [14]. Retroperitoneal lymph node dissection should be limited to patients with only radiologically suspicious lymph nodes [13]. Indications for adjuvant radiotherapy include positive margins or less than 10 mm and when the tumor is not resectable, because local recurrence following surgery alone is very high [15-17]. Cerda et al. [17] reported that adjuvant radiotherapy with a total dose of 54 Gy/27 or 30 fractions were found no recurrence in median 18 months of follow up (range 6 28 months). The prognosis of PLS depends on the histological cell type. The well-differentiated type have a better prognosis, but tend to have a high incidence of local recurrence [18]. Due to the paucity of cases, the role of adjuvant systemic chemotherapy in adult with PLS is not clear. When chemotherapy is indicated, treatment with vincristine, cyclophosphamide and doxorubicin is used for high grade and metastaic LPS [19].

Conclusion     

Often misdiagnosed preoperatively, paratesticular liposarcoma must be considered in the differential diagnosis of groin mass. Regardless of tumor size, radical orchidectomy with free surgical margins is recommended in order to avoid recurrence. The role of adjuvant therapies represented by radiotherapy and chemotherapy is controversial.

Competing interests     

The authors declare no competing interests.

Authors’ contributions     

Mouden Karima wrote the case report. Soukaina Wakrim and Afaf Semmar read and agreed to the final version of this manuscript.

Figures     

Figure 1: A) hematoxylin and eosin (H&E) staining showing lipoblasts with atypical nucleus indented on its surfaces by fat vacuoles; B) stromal cells with hyperchromatic nuclei

Figure 2: A) computed tomography showed a mass arising from groin region; B) computed tomography showed a left lateroplevic lipomatous mass extended to the iliac fossa and left parietocolic gutter measuring 15x7x17 cm repressing the bladder, sigmoid, left colon, some ileal loops and encompassing the left external iliac pedicle; C) computed tomography showed a lipomatous mass extended to the umbilicus repressing the left colon, some ileal loops and encompassing the left external iliac pedicle

References     

1. Unlü Y, Huq GE, Ozyalvaçli G, Zengin M, Koca SB, Yücetas U et al. Paratesticular sarcomas: a report of seven cases. Oncol Lett. 2015; 9(1): 308-312. PubMed | Google Scholar


2. Noguchi H, Naomoto Y, Haisa M, Yamatsuji T, Shigemitsu K, Uetsuka H et al. Retroperitoneal liposarcoma presenting a indirect inguinal hernia. Acta Med Okayama. 2001; 55(1): 51-54. PubMed | Google Scholar


3. Chiodini S, Luciani LG, Cai T, Molinari A, Morelli L, Cantaloni C et al. Unusual case of locally advanced and metastatic paratesticular liposarcoma: a case report and review of the literature. Arch Ital Urol Androl. 2015; 87(1): 87-89. PubMed | Google Scholar


4. Zuwei Li, Liang Zhou, Liwen Zhao, Peijie Chen, Yifeng Liu, Yu Ding et al. Giant paratesticular liposarcoma: A case report and review of the literature. Molecular and Clinical Oncology. 2018; 8(4): 617-622. PubMed | Google Scholar


5. Sopena Sutil R, Silan F, Butron Vila MT, Guerrero Ramos F, Lagaron Comba E, Passas Martinez J. Multidisciplinary approach to giant paratesticular liposarcoma. Can Urol Assoc J. 2016 Sep-Oct; 10(9-10): E316-E319. Epub 2016 Sep 13. PubMed | Google Scholar


6. Khoubehi B, Mishra V, Ali M, Motiwala H, Karim O. Adult paratesticular tumours. BJU International. 2002; 90(7): 707-715. PubMed | Google Scholar


7. Doyle LA. Sarcoma classification: an update based on the 2013 World Health Organization Classification of tumors of soft tissue and bone. Cancer. 2014; 120(12): 1763-1774. PubMed | Google Scholar


8. Coleman J, Brennan MF, Alektiar K. Adult spermatic cord sarcomas: management and results. Ann Surg Oncol. 2003; 10(6): 669-675. PubMed | Google Scholar


9. Robert Anthony Keenan, Aisling Riogh, Andrea S, Adrian F, Joan H, Ivor MC, Padraig JD. Paratesticular sarcomas: a case series and literature review. Ther Adv Urol. 2019; 11: 1756287218818029. PubMed | Google Scholar


10. Pergel A, Yucel AF, Aydin I, Sahin DA, Gucer H, Kocakusak A. Paratesticular liposarcoma: a radiologic pathologic correlation. J Clin Imaging Sci. 2011; 1: 57. Epub 2011 Dec 17. PubMed | Google Scholar


11. Li F, Tian R, Yin C, Dai X, Wang H, Xu N et al. Liposarcoma of the spermatic cord mimicking a left inguinal hernia: a case report and literature review. World J Surg Oncol. 2013; 11: 18. PubMed | Google Scholar


12. Alyousef H, Osman EM, Gomha MA. Paratesticular liposarcoma: a case report and review of the literature. Case Rep Urol. 2013: 2013; 806289. PubMed | Google Scholar


13. Vukmirovic F, Zejnilovic N and Ivovic J. Liposarcoma of the paratesticular tissue and spermatic cord: a case report. Vojnosanit Pregl. 2013; 70(7): 693-696. PubMed | Google Scholar


14. Khandekar MJ, Raut CP, Hornick JL, Wang Q, Alexander BM, Baldini EH. Paratesticular liposarcoma: unusual patterns of recurrence and importance of margins. Ann Surg Oncol. 2013; 20(7): 2148 2155. PubMed | Google Scholar


15. Raza M. Bilateral paratesticular liposarcoma-a rare case report. J Surg Tech Case Rep. 2014; 6(1): 15-17. PubMed | Google Scholar


16. Schoonjans C, Servaes D, Bronckaers M. Liposarcoma scroti: a rare paratesticular tumor. Acta Chirurgica Belgica. 2016 Apr; 116(2): 122-5. Epub 2016 Apr 21. PubMed | Google Scholar


17. Cerda T, Martin É, Truc G, Créhange G, Maingon P. Safety and efficacy of intensity modulated radiotherapy in the management of spermatic cord sarcoma. Cancer Radiother. 2017; 21(1): 16-20. PubMed | Google Scholar


18. Vinayagam K. Paratesticular liposarcomamasquerading as a testicular tumour. J Clin Diagn Res. 2014; 8(2): 165-166. PubMed | Google Scholar


19. Rodriguez D, Olumi AF. Management of spermatic cord tumours: a rare urologic malignancy. Ther Adv Urol. 2012; 4(6): 325-34. PubMed | Google Scholar